Medical News
Addiction
Allergies
Alternative Medicine
Asthma
Cancer
Cardiology
Chiropractic
Dental
Dermatology
Diabetes
Emergency
Family Medicine
General
Geriatrics
Hospitals
Infectious Diseases
Internal Medicine
Managed Care / HMO
Medical Products
Mental Health
Neurology
Nursing
Nutrition
OB / GYN
Pediatrics
Pharmaceuticals
Physical Therapy
Plastic Surgery
Psychology
Radiology / Imaging
Research
Sports Medicine
Surgery
Vision

New Reaction Block for Organic Synthesis and Process Screening

Press Release Attachment
Press Release Attachment

METTLER TOLEDO recently launched the MiniBlock® XT-S, an affordable reaction block for Organic Synthesis and Process Screening.

Columbia, MD (PRWEB) May 29, 2008 -- METTLER TOLEDO recently launched the MiniBlock® XT-S, an affordable reaction block for Organic Synthesis and Process Screening.

MiniBlock® XT-S enables the chemist to save time and valuable starting materials by utilizing small scale parallel synthesis to answer important research questions. The XT-S has removable racks which easily change the scale and array providing flexibility for your project needs. The XT-S is part of the MiniBlock® product family, which is the only compact parallel synthesizer that enables solid phase synthesis, solution phase synthesis, and purification to be carried out on the same platform. Applications for MiniBlock® include parallel solid phase synthesis, parallel solution phase synthesis, process screening and process route scouting.

###

Simillar Articles

Ash Stevens Enhances Speed and Safety of Scale-Up with New Investments in Parallel Synthesis and...
Ash Stevens Incorporated (ASI), a full service cGMP contract manufacturer, enhanced the speed and safety of scale-up with new investments in parallel synthesis and calorimetry instrumentation at...
The First Automated Synthesis Tool That Requires No Training: EasyMax™ 102
Mettler Toledo introduces EasyMax™ 102, the new generation automated lab reactor system for the synthesis lab and the synthetic organic chemist. EasyMax™ 102 replaces the traditional...
AsisChem Expands Chemical Catalog
Cambridge-based AsisChem continues to grow its catalog and expand its distribution partnerships.
Genome Synthesis and Design Futures: Implications for the U.S. Economy
Bio-era releases new report analyzing economic implications of rapid advances in gene sequencing and synthesis technologies -- big changes coming for energy, chemicals, and vaccine production.
DNA2.0 Expands European Presence By Opening UK Office: Experienced Life Sciences Executive, Dr....
DNA2.0 opens DNA2.0 Ltd. in the United Kingdom and hires Michael Dyson to run European operations.
Home Terms of Use Privacy Policy Contact Us